Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 193

Similar articles for PubMed (Select 17327416)

1.

Antitumor effects of HSV-TK-engineered donor lymphocytes after allogeneic stem-cell transplantation.

Ciceri F, Bonini C, Marktel S, Zappone E, Servida P, Bernardi M, Pescarollo A, Bondanza A, Peccatori J, Rossini S, Magnani Z, Salomoni M, Benati C, Ponzoni M, Callegaro L, Corradini P, Bregni M, Traversari C, Bordignon C.

Blood. 2007 Jun 1;109(11):4698-707. Epub 2007 Feb 27.

2.

The potential immunogenicity of the TK suicide gene does not prevent full clinical benefit associated with the use of TK-transduced donor lymphocytes in HSCT for hematologic malignancies.

Traversari C, Marktel S, Magnani Z, Mangia P, Russo V, Ciceri F, Bonini C, Bordignon C.

Blood. 2007 Jun 1;109(11):4708-15. Epub 2007 Feb 27.

3.
4.

Thymidine kinase (TK) gene-transduced human lymphocytes can be highly purified, remain fully functional, and are killed efficiently with ganciclovir.

Munshi NC, Govindarajan R, Drake R, Ding LM, Iyer R, Saylors R, Kornbluth J, Marcus S, Chiang Y, Ennist D, Kwak L, Reynolds C, Tricot G, Barlogie B.

Blood. 1997 Feb 15;89(4):1334-40.

5.

Prophylaxis of graft-versus-host disease by lentiviral-mediated expression of herpes simplex virus-thymidine kinase and ganciclovir treatment.

Xu K, Zhu F, Du B, Gao F, Cheng H, Pan X.

Transplant Proc. 2008 Oct;40(8):2665-9. doi: 10.1016/j.transproceed.2008.08.063.

PMID:
18929831
6.

Modulation of GvHD by suicide-gene transduced donor T lymphocytes: clinical applications in mismatched transplantation.

Ciceri F, Bonini C, Gallo-Stampino C, Bordignon C.

Cytotherapy. 2005;7(2):144-9. Review.

PMID:
16040393
7.

Herpes simplex thymidine kinase gene-transduced donor lymphocyte infusions.

Burt RK, Drobyski WR, Seregina T, Traynor A, Oyama Y, Keever-Taylor C, Stefka J, Kuzel TM, Brush M, Rodriquez J, Burns W, Tennant L, Link C.

Exp Hematol. 2003 Oct;31(10):903-10.

PMID:
14550806
8.

Human HLA-specific T-cell clones with stable expression of a suicide gene: a possible tool to drive and control a graft-versus-host- graft-versus-leukemia reaction?

Gallot G, Hallet MM, Gaschet J, Moreau JF, Vivien R, Bonneville M, Milpied N, Vié H.

Blood. 1996 Aug 1;88(3):1098-103.

9.

Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft.

Tiberghien P, Ferrand C, Lioure B, Milpied N, Angonin R, Deconinck E, Certoux JM, Robinet E, Saas P, Petracca B, Juttner C, Reynolds CW, Longo DL, Hervé P, Cahn JY.

Blood. 2001 Jan 1;97(1):63-72.

10.

Deletions within the HSV-tk transgene in long-lasting circulating gene-modified T cells infused with a hematopoietic graft.

Deschamps M, Mercier-Lethondal P, Certoux JM, Henry C, Lioure B, Pagneux C, Cahn JY, Deconinck E, Robinet E, Tiberghien P, Ferrand C.

Blood. 2007 Dec 1;110(12):3842-52. Epub 2007 Aug 23.

11.

Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: an approach for specific in vivo donor T-cell depletion after bone marrow transplantation?

Tiberghien P, Reynolds CW, Keller J, Spence S, Deschaseaux M, Certoux JM, Contassot E, Murphy WJ, Lyons R, Chiang Y, et al.

Blood. 1994 Aug 15;84(4):1333-41.

12.

Ganciclovir-mediated elimination of HSV-Tk+ T cells and cure of graft-vs-host disease in an allogeneic bone marrow transplantation model in the rat.

Weijtens M, van Spronsen A, Hagenbeek A, de Weger R, Martens A.

Exp Hematol. 2004 Oct;32(10):962-9.

PMID:
15504552
13.

Transfer of the HSV-tk gene into donor peripheral blood lymphocytes for in vivo modulation of donor anti-tumor immunity after allogeneic bone marrow transplantation.

Bordignon C, Bonini C, Verzeletti S, Nobili N, Maggioni D, Traversari C, Giavazzi R, Servida P, Zappone E, Benazzi E, et al.

Hum Gene Ther. 1995 Jun;6(6):813-9.

PMID:
7548281
14.

Ganciclovir-sensitive acute graft-versus-host disease in mice receiving herpes simplex virus-thymidine kinase-expressing donor T cells in a bone marrow transplantation setting.

Contassot E, Ferrand C, Angonin R, Cohen JL, de Carvalho Bittencourt M, Lorchel F, Laithier V, Cahn JY, Klatzmann D, Herve P, Tiberghien P.

Transplantation. 2000 Feb 27;69(4):503-8.

PMID:
10708102
15.

Graft-versus-leukemia effect after suicide-gene-mediated control of graft-versus-host disease.

Litvinova E, Maury S, Boyer O, Bruel S, Benard L, Boisserie G, Klatzmann D, Cohen JL.

Blood. 2002 Sep 15;100(6):2020-5.

16.

[Experimental study of the inhibiting effect of the lentiviral vector mediated herpes simplex virus-thymidine kinase/ganciclovir on GVHD].

Xu KL, Zhu F, Du B, Gao F, Cheng H, Pan XY.

Zhonghua Xue Ye Xue Za Zhi. 2007 May;28(5):303-7. Chinese.

PMID:
17877157
18.

Suicide-gene-Transduced donor T-cells for controlled graft-versus-host disease and graft-versus-tumor.

Ciceri F, Bordignon C.

Int J Hematol. 2002 Nov;76(4):305-9. Review.

PMID:
12463592
19.

Selective T-cell subset ablation demonstrates a role for T1 and T2 cells in ongoing acute graft-versus-host disease: a model system for the reversal of disease.

Liu J, Anderson BE, Robert ME, McNiff JM, Emerson SG, Shlomchik WD, Shlomchik MJ.

Blood. 2001 Dec 1;98(12):3367-75.

20.

Suicide gene therapy of graft-versus-host disease induced by central memory human T lymphocytes.

Bondanza A, Valtolina V, Magnani Z, Ponzoni M, Fleischhauer K, Bonyhadi M, Traversari C, Sanvito F, Toma S, Radrizzani M, La Seta-Catamancio S, Ciceri F, Bordignon C, Bonini C.

Blood. 2006 Mar 1;107(5):1828-36. Epub 2005 Nov 17.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk